FeesSafety
Pluang+

SIGA Technologies to host business update call on Nov 9 after Q3 2026 results

Company Fundamentals
29 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Neutral
SIGA Technologies to host business update call on Nov 9 after Q3 2026 results

SIGA Technologies announced a webcast and conference call scheduled for November 9, 2026, at 4:30 P.M. ET to discuss its third-quarter 2026 financial results and provide a business update. CEO Diem Nguyen and CFO Daniel Luckshire will lead the call, which will be accessible live on the company's website and via phone. This event is important for investors to gain insights into SIGA's recent performance and future outlook, especially given its focus on infectious disease treatments. A replay will be available for two weeks after the call.

SIGA Technologies' upcoming business update call is presented here with Pluang's health sector market data as context. For readers following the health sector, here is Pluang's market snapshot as of Oct 29, 2026 18:11 WIB: Among 150 priced health-sector US stocks, 95 rose and 47 fell today. Eli Lilly And Co (LLY) gained 4.11% to USD 1,341.75 with a typical hold time of 94 days and a buy order activity of 71%, contrasting with Tenet Healthcare Corporation (THC), which dropped 5.10% to USD 254.80 with a shorter hold time of 17 days. Amgen, Inc. (AMGN) also rose 3.62% to USD 468.17 with a hold time of 73 days and 82% buy orders.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App